{"input_url":"https://www.medscape.com/viewarticle/fda-expert-panel-backs-compounding-six-peptides-2026a1000pgw","gnews_decode":"https://www.medscape.com/viewarticle/fda-expert-panel-backs-compounding-six-peptides-2026a1000pgw","http_status":200,"final_url":"https://www.medscape.com/viewarticle/fda-expert-panel-backs-compounding-six-peptides-2026a1000pgw","html_length":680751,"trafilatura_result":"ok","text_length":6363,"text_preview":"An FDA advisory panel recommended adding six peptides to a drug compounding list, the first step in a process that could allow clinicians and telehealth providers to prescribe them and pharmacists to produce them as therapies for any disease or condition.\nEven if the agency follows the panel’s advic","verdict":"OK"}